South Korea to Shorten Healthcare Pricing Review Cycle
Hwang Sujin Reporter
hwang075609@gmail.com | 2024-12-29 19:33:16
Seoul, South Korea – South Korea’s Ministry of Health and Welfare announced today that it will shorten the review cycle for healthcare pricing from the current 5-7 years to 2 years. This move is aimed at addressing the longstanding imbalance in healthcare reimbursement, where basic treatments and surgeries are undercompensated while diagnostic tests, such as imaging and lab work, are overcompensated.
The decision was made at the Health Insurance Policy Deliberation Committee (HIPDC) meeting held on 28th. The committee also discussed various other healthcare-related issues, including the performance evaluation of health insurance pilot projects and the expansion of dental coverage.
A recent analysis by the committee found that the current pricing system for healthcare services is distorted, favoring diagnostic procedures over basic treatments. This imbalance has led to concerns about the quality of care and the sustainability of the healthcare system.
To address this issue, the government will conduct more frequent reviews of healthcare pricing, allowing for quicker adjustments to ensure that healthcare providers are fairly compensated for the services they provide. The ministry also plans to expand the scope of these reviews to include a wider range of healthcare institutions.
"By shortening the review cycle, we can better reflect the changing healthcare landscape and ensure that our healthcare system is sustainable and equitable," said [Name], a spokesperson for the Ministry of Health and Welfare.
In addition to the changes to the pricing review cycle, the HIPDC approved the extension of 12 health insurance pilot projects, including those for intensive care for critically ill children and in-depth consultations at tertiary hospitals. The committee also decided to expand the coverage of certain mental health services.
WEEKLY HOT
- 1Tesla Model Y Becomes First to Pass Grueling New U.S. Autonomous Safety Tests
- 2Celltrion’s Zymfentra Sees Explosive 300% Growth, Hits Record Quarterly Prescriptions in the U.S.
- 3BMW Korea Ignites May with Exclusive 9-Model Online Limited Edition Lineup
- 4Hyundai Mobis Completes Independent EV 'Heart' Lineup: A Major Leap Toward Global Leadership in Power Electric Systems
- 5OpenAI Redefines Human-AI Interaction with ‘GPT-Realtime-2’ and New Suite of Live Voice Models
- 6Tensions Flare in Strait of Hormuz: U.S.-Iran Clashes Threaten Fragile Truce